CDMO– tag –
-
Sartorius Unveils Upgraded BIOSTAT STR Single-Use Bioreactor Family, Enhancing Biologics Scalability
Pharmaceutical Technology USA Overview Sartorius Stedim Biotech has released an enhanced BIOSTAT STR single-use stirred-tank bioreactor family, featuring upgraded hardware, software, and new Flexsafe STR bags. This scalable system suppor... -
GLP-1 Drug Manufacturing Surges: CDMOs Scale Peptide Synthesis, Driving Technology Transfer
IntuitionLabs USA Overview Driven by soaring GLP-1 demand, Contract Development and Manufacturing Organizations (CDMOs) are rapidly expanding peptide synthesis capabilities. Industry reports project the GLP-1 peptide CDMO market to grow ... -
Samsung Biologics Labor Dispute Stalls Wage Talks, Raising Concerns for Global CDMO Competitiveness
The Elec Inc. South Korea Overview Wage negotiations between management and labor union at Samsung Biologics have reached a prolonged stalemate, raising concerns about the company's global competitiveness in the Contract Development and ... -
Thousand Oaks Biologics Honored with Forbes China Industry Award for Leading ADC CDMO Capabilities
TMX Newsfile China Overview Thousand Oaks Biologics has been awarded the "2026 Forbes China Industry Development Leading Enterprise Award" for its advanced capabilities in antibody-drug conjugate (ADC) manufacturing. Operating across Chi... -
FUJIFILM Cellular Dynamics Quadruples iPSC Manufacturing Capacity with New Madison Facility
FUJIFILM Cellular Dynamics USA Overview FUJIFILM Cellular Dynamics (FCDI) has inaugurated a new headquarters and iPSC development and manufacturing facility in Madison, Wisconsin. This strategic expansion quadruples FCDI's capacity for p... -
Lonza Reports Strong Q1 2026 Performance, Driven by Robust CDMO Growth and Strategic Transformation into Pure-Play Biopharma Partner
Lonza Switzerland Overview Lonza delivered strong Q1 2026 performance across its Contract Development and Manufacturing Organization (CDMO) business, aligning with full-year expectations despite macroeconomic challenges. The company secu... -
Pharmaceutical Membrane Filtration Market: Size, Share, and Growth Forecast to 2034 – A Straits Research Overview
Straits Research Germany Overview This article provides an overview of a market research report published by Straits Research, detailing the pharmaceutical membrane filtration market's current status and projected growth to 2034. The rep... -
ProBio and Curocell Achieve BLA Approval for Next-Gen CD19-Targeted CAR-T Therapy, Initiating Commercial Production in South Korea
ProBio CDMO South Korea Overview ProBio CDMO and Curocell have secured Biologics License Application (BLA) approval for anbalcabtagene autoleucel (Anbal-cel; CRC01), their next-generation CD19-targeted CAR-T cell therapy for relapsed or ... -
Ajinomoto Develops Novel Culture Medium Supplement to Boost Gene Therapy Drug Productivity, Accelerating Biomanufacturing Efficiency
味の素株式会社 IRニュース Japan Overview Ajinomoto Group, in collaboration with its U.S. subsidiary Forge Biologics (acquired in 2023 for ~¥82.8 billion), has developed a novel culture medium supplement designed to significantly enhance ... -
Helios Advances ARDS Therapy Approval, Bolstering Regenerative Medicine CDMO with New Kobe Manufacturing Hub
FISCO Japan Overview Helios is progressing towards regulatory approval for its Acute Respiratory Distress Syndrome (ARDS) therapeutic, HLCM051, while simultaneously enhancing its Contract Development and Manufacturing Organization (CDMO)...
